Losing just 6.5% of body weight in midlife may lower later risk of disease and premature death, new research shows.

By Dennis Thompson HealthDay ReporterWEDNESDAY, May 28, 2025 (HealthDay News) — Popular GLP-1 weight loss drugs like Ozempic ...

Gabby tried a variety of weight loss methods, without results. She also found out that because of her past health issues, she ...

GLP-1 receptor agonists may modestly reduce the risk for 14 obesity-related cancers, especially colorectal cancer, among ...

The supply of GLP-1 drugs like Ozempic has been increasing, but they’re still expensive for most patients. Here are answers ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

To others, one of its main side effects—sudden, fast weight loss—means its appeal lies solely in the significant amount of ...

Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...

Rosie O'Donnell, who's been opening up about her weight-loss journey online, celebrated her progress in a new post.

Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when ...

The weight-loss industry is a huge one in the U.S. Numbers say it all, and the global weight management market size was ...

Microdosing isn’t just popular for psychedelics. Some consumers are taking smaller than standard doses of GLP-1s—the popular ...